Fig. 3From: The frequencies of CYP2D6 alleles and their impact on clinical outcomes of adjuvant tamoxifen therapy in Syrian breast cancer patientsKaplan–Meier estimates of DFS according to CYP2D6 phenotypes in the successfully genotyped patients (n = 95). A. all metabolizer groups. B. PM vs. IM and NM combinedBack to article page